B

Braveheart Bio

Develops cardiac myosin inhibitors for HCM

Clinical Trial Manager

Clinical Research OperationsConfirmed live in the last 24 hours
Full-timeSan Francisco, CA, USA

About the Job

Requirements

  • At least 4 years of relevant experience and a Bachelor of Science or Bachelor of Arts in a relevant scientific discipline, or an RN (2- or 3-year certificate).
  • Relevant clinical trial experience in the pharmaceutical or health care industry.
  • Excellent attention to detail, interpersonal skills, and presentation skills.
  • Excellent organizational, problem-solving, and time-management skills.
  • Familiarity with routine medical and scientific terminology.
  • Knowledge of FDA and/or EMEA regulations, ICH guidelines, and GCPs governing clinical trials is desirable.
  • Familiarity with Word, PowerPoint, and Excel; intermediate or higher Excel proficiency is a plus.
  • Ability to participate in departmental or interdepartmental strategic initiatives under general supervision.
  • Strong written and verbal communication skills and a collaborative, team-oriented approach.
  • Ability to work in a fast-paced, dynamic environment and remain comfortable with change and ambiguity.
  • Flexible, proactive, hands-on approach.
  • Ability to obtain valid travel documents.

Responsibilities

  • Manage day-to-day activities within assigned regions, including site selection, start-up, maintenance, and close-out activities; with guidance, serve as an operational contact for studies and coordinate study-site selection, implementation, and ongoing activities directly or through CROs.
  • Assist the Clinical Program Manager, Clinical Operations with CRO oversight and vendor setup, including liaising with the global CRO to support timely study initiation.
  • Serve as a day-to-day contact for CRO and/or trial-site counterparts; review daily for potential issues and communicate or escalate them to the Clinical Program Manager, Clinical Operations.
  • Review site informed consent forms and escalate them as needed; assist with review of regional regulatory submission packages.
  • Identify potential operational challenges and collaborate with senior team members on solutions to keep study execution on track.
  • Conduct accompanied visits (PSSVs, SIVs, and RMVs) with CRO CRAs to ensure study procedures follow SOPs and protocol procedures; review routine regulatory documents and files for compliance with the protocol, regulatory requirements, SOPs, and Monitoring Plan as required.
  • With guidance, assist with review of protocols, informed consents, case report forms, monitoring plans, abstracts, presentations, manuscripts, and clinical study reports; assist with investigator brochure appendix compilation under close supervision.
  • Review CRO CRA trip reports for trends and quality issues.
  • Review protocol deviations and monitor for trends.
  • Coordinate review of data listings and preparation of interim and final clinical study reports, including resolving data discrepancies.
  • Provide regular study updates to appropriate internal stakeholders.
  • Maintain internal Clinical Operations databases and document repositories.
  • Perform administrative duties in a timely manner as assigned.
  • Guide and support junior team members, ensuring alignment on deliverables, timelines, and quality standards.
  • Participate in domestic or international travel as needed, up to 25%.

Desired Qualifications

  • Experience as the regional lead for Europe is strongly preferred.
  • Knowledge of FDA and/or EMEA regulations, ICH guidelines, and GCPs governing clinical trials.
  • Intermediate or higher Excel proficiency.

About the Company

Braveheart Bio

Develops cardiac myosin inhibitors for HCM

Braveheart Bio develops therapies for hypertrophic cardiomyopathy by in-licensing promising drug candidates and advancing them through late-stage clinical trials. Its lead drug, BHB-1893, is a selective small-molecule cardiac myosin inhibitor licensed from Hengrui Pharma for ex-China rights, designed to reduce contractility in heart cells and improve heart performance. The company differentiates itself by pursuing a best-in-class profile with potential improvements in efficacy, safety, and dosing, supported by a high-profile leadership team and investors. Its goal is to bring an approved, globally accessible therapy for HCM that delivers meaningful clinical benefit.

Company size
51-200
Company stage
IPO
Headquarters
San Francisco, CA
Founded
2025

Recently Posted Jobs

Explore more opportunities at Braveheart Bio

See more jobs